Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
11 million shares traded and pps holding at .20 with absolutely no news at all. We seriously do not know if an auction is ongoing and if so how many bidders are involved.
I am both optimistic and fatalistic at the same time.
Opti
* * $SGYP Video Chart 02-25-2019 * *
Link to Video - click here to watch the technical chart video
I think no news is good news so far. Next step should be an announcement some time this evening. Hopefully it is positive--that they have multiple bidders for tomorrow's auction.
The price of shares trading today makes me believe no one knows what is going on. Early selling was probably just from fear. But, there are also no buyers, so we remain in limbo.
So, if there are other bidders, then we should hear the names of the bidders before the open tomorrow.
I admit I am praying for a good result.
Opti
We will see when the bids are revealed tomorrow. PM today looked like a shake.
well what do you think opti. no kind of any announcement before the opening. could there be a buyer out there? I guess only time will tell. I thought with the drop before opening, a lot of the recent buyers got worried and dropped out.
Yikes. Thinking flip time is over for now unless you have steel *****.
I guess, and it is purely a guess here, that if we do not have a press release before open then there may indeed be a second bidder. We won't know for sure until I guess at the latest tomorrow. Note: there could be a bidder that needs to be vetted today for the auction tomorrow.
Opti
Saw multiple posts on another board that there was at least one bidder (other than BHC). Possibly a Chinese Pharma. We’ll see soon enough.
Troy's document states he met with 8 companies. The main document states that access to the data room was offered to 131 companies, but does not state how many took advantage of the offer.
There is no information regarding bids. As far as we know no company offered a bid other than the Stalking Horse. But, we should hear officially tomorrow. If there is more than one bidder, then the auction will be held on Tuesday.
Given the preparation of plan B by the ad hoc committee, it appears there are no bidders and the auction will be cancelled and the Stocking Horse bid accepted and the shareholders loosing totally. If this is announced tomorrow before the bell, the stock will immediately go to zero. If it is not announced, the panic will probably drive the price to near zero.
Trouble and more trouble.
Opti
Tom, if you have read 451, what is your opinion?
Synergy Pharmaceuticals Wins Approval for Bankruptcy Loan
Drugmaker can draw down remainder of $155 million financing package over protests from shareholders
By Tom Corrigan
Feb. 22, 2019 5:48 p.m. ET
Synergy Pharmaceuticals Inc. won court permission to draw down the remainder of a $155 million bankruptcy financing package, overcoming roadblocks imposed by a newly empowered committee of shareholders.
hello Opti. correct me if I am wrong but i looked at docket 431 and it appears to me as if there has been at least 8 and maybe as many as 13 bids as shown in that document.
https://cases.primeclerk.com/synergy/Home-DocketInfo
This is the court docket. Everything you ever wanted to know regarding the case.
Opti
I have read most everything on SGYP. Been in it a LONG time.
there is a motion to extend this thing for 6 weeks. that will be determined in about a week or so. there is a lot going on here as a result of those w;ho represent sygp and those who claim to be officers of holding back information relative to this bankruptcy. get to read the motions and you will understand it all.
Auction is Tuesday Feb 26, I believe 10 am Eastern. More "the opening of the bids" - there will not be a "going once, going twice...SOLD!" kind of interactive auction - bidders submit bids in advance and high bidder wins.
Although it may take a day or so for a PR to come out, we'll probably see the numbers on the internet (here, StockTwits) pretty quickly.
Actually one of the news items indicates that a "sale hearing" will be conducted on March 1, which is probably when things become official and the role of the bankruptcy court ends.
Right now the Bausch offer is for an asset purchase, not to buy the whole company. Bausch (or a higher bidder would pay the money to SGYP and take SGYP assets.
Since this deal is being brokered under the bankruptcy court auction, the money would go first to pay off debts, If there is anything left over SGYP could liquidate and distribute the remaining cash to shareholders.
Another bidder could come in higher for the assets - essentially Trulance (and some early stage IP on another drug that is not worth much and not material to the discussion), or could buy the whole company (pretty much the same deal for shareholders but more complicated paperwork).
So all debts are paid and synergy gets the stock 214 million plus
Lest that be misinterpreted, I believe all the debt payments and fees would have to come out of that number before shareholders get anything.
At 248 mil shares outstanding, (etrade), the PPS for a sale of synergy ph. To bausch health would be .867 cents per share
If they sell to bausch health, how much per share is it??
Can you tell when the auction will be?
I have been doing a lot of reading and absorbing facts a figures re: who might be the best purchaser of sgyp in the upcoming auction. without a doubt the company that would do best in this whole transaction would be Takeda. when they acquired Shire I thought was a wise move on their part. putting a bid for sgyp would even be a no brainer on their part for advancing their position in the pharm.industry, especially with the know how and performance that has been shown with a drug like Trulance. their own competing product is just fading in the market place.this would be great effort to control and dominate sales in that field. just a thought on my part. I am a retired executive in the petro/chem. and pharm. industries who has been around some deals like this in my past.
What did you find?
* * $SGYP Video Chart 02-05-2019 * *
Link to Video - click here to watch the technical chart video
* * $SGYP Video Chart 02-04-2019 * *
Link to Video - click here to watch the technical chart video
* * $SGYP Video Chart 01-31-2019 * *
Link to Video - click here to watch the technical chart video
Is interest in this stock dying down? I saw that they just appointed an official committee of equity security holders.
https://cases.primeclerk.com/Synergy/Home-DownloadPDF?id1=MTA1MjkyNQ==&id2=0
* * $SGYP Video Chart 01-30-2019 * *
Link to Video - click here to watch the technical chart video
* * $SGYP Video Chart 01-28-2019 * *
Link to Video - click here to watch the technical chart video
* * $SGYP Video Chart 01-25-2019 * *
Link to Video - click here to watch the technical chart video
OK thanks. I'll do some research.
QOL Medical. Private company. In the business of acquiring and marketing orphan drugs.
Opti
This is a dumb question, but who is QOL?
Yahoo Post: the urge to provide additional context on QOL's potential role in the SGYP stalking horse bid process. QOL see's financial value by purchasing SGYP shares as a hedge against their upcoming bid. Based on today's volume (and likely tomorrow's too), it will confirm that QOL has moved forward with their share purchase, and have made a decision to enter a bid that will exceed the current, and be greater than today's current share price. One can assume, QOL will have ~50M shares at an avg ~ $0.40/share ($20M investment). One could feel confident that their best bid will exceed current debt + their avg.price/sh. In doing so, they have created a floor for those who are already invested. It's best that those who currently own shares hold until 2/23, as there will only be upside from today's closing price. Purchasing at a higher level than this floor price does create some risk given the final bid is unknown. I have seen these play out, and most companies typically delay their submission until the final day. If QOL wins the bid, they now pay themselves back for the 50M shares, at the higher price they created. If a higher bid comes in, they walk away with a financial gain. So it's a legal and common win-win strategy that can exist in a stalking horse bid scenarios. As an example, let's say QOL's best bid is $600M (~$1,50/share - after covering current debt), they walk away with the patents,and discount their bid by $75M via the purchase of shares. These shares allow QOL to leverage additional capital to provide a best bid. In addition, they can sell-off some of the assets (ie Dolcanatide), which further allows them to discount their best price. Let's say they sell-off that DOLC for $100M (or higher, based on upcoming results). Their final net purchase of Plec will be $425M. Recall, up until Mgmt made their announcement in October, the MC on SGYP assets were ~ $425M. If QOL isnt the high bidder, they walk away with the value of their shares, which generates $75M in 20 days, minus their initial $20M investment . Again, a creative and strategic way to leverage their position, provide a best bid price, while generating no financial risk to the organization. I have seen a few interesting posts, and respect everyone's opinion. Just wanted to share some insight from my years of experience working for a small NYC hedge fund. We will all see how this plays out in the next month. Good luck to all the bulls & bears out there. With much respect - JM
Thumbs up! Incredible vol. Just got in, will try to see what is up. GLTY
* * $SGYP Video Chart 01-24-2019 * *
Link to Video - click here to watch the technical chart video
Buying the dip
SGYP
Can SGYP get out of the grave?
Any reason if this still worth holding shares?
* * $SGYP Video Chart 01-22-2019 * *
Link to Video - click here to watch the technical chart video
Opti - i will invest more today. thank you!
I would guess QOL Medical will be bidding based on their declared intent to purchase up to 40 million additional shares (In addition to the 11 million they already own) and their company goal of: The Company is interested in acquiring and partnering with pharmaceutical assets in late Phase II through commercially approved stages in the metabolic and pediatric gastrointestinal therapeutic areas. $https://www.qolmed.com/About-QOL.html
Opti
Followers
|
116
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4273
|
Created
|
08/10/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |